Board of Directors

     In accordance with the Articles of Association, the Company has seven to eleven directors for a term of three years and adopts the candidate nomination system. Among the above directors, the minimum number of independent directors shall not be less than three and not less than one fifth of the seats in the board. The Company elected the 7th Board of Directors (seven directors, including four independent directors) at the general meeting of shareholders in August 2021 for a term from August 18, 2021 to August 17, 2024. In order to establish a sound governance system of the board of directors with improved and strengthened supervision and management, the “Regulations Governing Procedure for Board of Directors Meetings” is hereby formulated for compliance in accordance with the stipulation of the “Regulations Governing Procedure for Board of Directors Meetings of Public Companies”.

 Resume of Directors 

Title

Name

Main experiences (education background)

Chairman

Huang, Shan-Ney

PhD of Michigan State University

Mr. Huang once served as the Director of Agriculture and Food Agency, Council of Agriculture, Executive Yuan and the Director of Tainan District Agricultural Research and Extension Station, Council of Agriculture, Executive Yuan.

At present, he also serves as the Chairman of Microbio Co., Ltd. and Harmony Organic Agriculture Foundation in addition to the Chairman of Oneness Biotech Co., Ltd.

Director

Kuo, Hsien-Shou

PhD, Faculty of Pharmacy, Meijo University

Mr. Kuo is the professor of Taipei Medical University in addition to the representative of legal director of Oneness Biotech Co., Ltd. and the independent director of TaiRx, Inc.

Director

Hsu, Shih-Hua

Bachelor of Applied Economics, National Chung Hsing University

Mr. Hsu once served as the Deputy Manager in the Trust Department, the Deputy Manager in the Savings Department and the Branch Manager of Chinfon Commercial Bank Co., Ltd.

Independent Director

Huang, San-Kuei

Master of Hospital and Health Care Administration, National Yang-Ming University

Mr. Huang once served as the Director of Central Health Insurance Agency, Ministry of Health and Welfare.

At present, he is also the consultant of Taipei Medical University and the physician of Saint. Mary's Hospital Taitung, in addition to the independent director of Oneness Biotech Co., Ltd.

At present, she is also the Manager in the Finance Department of 3D Global Biotech Inc. in addition to an Independent Director of Oneness Biotech Co., Ltd.

Independent Director

Wu, Rey-Yuh

PhD of National Taiwan University

Ms. Wu once served as the senior researcher in Development Center for Biotechnology.

Independent Director

Lu, Suei

Bachelor of International Business, Tunghai University

Ms. Lu once served as the Assistant Manager in the Management Department of Microbio Co., Ltd.

Independent Director

Huang, Jui-Wen

Bachelor of Accounting, Shih Chien University

Ms. Huang once served as the senior manager in Finance Department of First International Telecom Corp.

At present, she is also the manager in Finance Department of 3D Global Biotech Inc., in addition to the independent director of Oneness Biotech Co., Ltd.


Diversification of Board Members:

     The Company has stipulated in the “Corporate Governance Best Practice Principles” that the board of directors shall be diversified, which means appropriate diversification policies should be formulated according to the operation, business models and development needs, except that the number of directors who concurrently serve as the managers of the Company should not exceed one third of the seats in the board. At present, only the Chairman also serves as the general manager of the Company, which is less than one third of the seats in the board. Moreover, the members of the board of directors possess financial and industrial background in terms of professional knowledge and skills. Director Kuo, Hsien-Shou is the professor of Taipei Medical University, Director Huang, San-Kuei was the Director of Central Health Insurance Agency, Ministry of Health and Welfare, Director Wu, Rey-Yuh was the senior researcher in Development Center for Biotechnology, Director Huang, Jui-Wen is the current Financial Manager of 3D Global Biotech Inc., all of them are professionals and familiar with the industrial development. Among the board of directors, 14% are also the Company’s employee, 57% are independent directors and 43% are female. Three directors are over 70 years old, two are between 60 and 69 years old, and two are under 60 years old. The Company attaches great attention to gender equality in the composition of the board of directors, and the percentage of female directors has reached more than 30%. Therefore, the Company does implement the diversification policy stipulated in the Best Practice Principles.

   

  Performance Evaluation of the Board of Directors 
   
     The Company revised the “Rules for Performance Evaluation of Board of Directors” on September 30, 2020, and carried out the performance evaluation regularly in accordance with the provisions of the Rules. The performance evaluation of the board of directors of 2020 has been completed according to the indicators listed in the Rules, and the evaluation results has been reported in the third board of directors meeting of 2021 (held on April 6, 2021).
 
The performance evaluation of the Board of Directors of the Company includes five aspects as follows:
 
1. Participation in the operation of the Company
2. Improvement of the decision-making quality of the Board of Directors
3. Composition and structure of the Board of Directors
4. Selection and continuing education of directors
5. Internal control
    
The result of the performance evaluation of the Board of Directors of 2020 is “Excellent”, and the overall operation of the board of directors is in good condition. In addition, the Company has disclosed the “Rules for Performance Evaluation of Board of Directors” on the website for reference.
 
https://www.onenessbio.com.tw/file/Board%20Performance/109.pdf